arrow
Back
L

Larry D. Anderson

UT Southwestern Medical Center

35H-index
359Paper Count
7.8KCitation Count
Published Papers 65
Publication Date
When Myeloma Escapes the Bone Marrow: Extramedullary Disease in the Immunotherapy Era
errCancers
IF4.4
err2026-08-18
err0
errOAAI
errAimaz Afrough; Christen M. Dillard; Anne M. Alsup; Jimmy Lee; Samer Al Hadidi; Aishwarya Sannareddy; Pearl R. Abraham; Laura Turer; Danai Dima; Adeel M. Khan; Sean M. Taasan; Oren Pasvolsky; Krina K. Patel; Abdel Kareem Azab; Larry D. Anderson, Jr.; Mahmoud R. Gaballa
errShare
errSave
Impact of extramedullary plasmacytoma on outcomes in patients with relapsed refractory multiple myeloma treated with talquetamab: U.S. Myeloma Immunotherapy Consortium
err2026-07-27
err0
errOAAI
errAimaz Afrough; Oren Pasvolsky; Andrew J. Portuguese; Saurabh Zanwar; Mahmoud R. Gaballa; Aishwarya Sannareddy; Danai Dima; Utkarsh Goel; Hossam M. Ali; Kelley Julian; Andre De Menezes Silva Corraes; Murali Janakiram; Scott Goldsmith; James A. Davis; Kimberly Green; Noa Biran; Lindsay Fogel; Eli Zolotov; Megan M. Herr; Hamza Hassan; Leyla Shune; Jeries Kort; Christina Ye; Susan Bal; Luciano J. Costa; Laura Joiner; Samer AL Hadidi; Adeel M. Khan; Shahzad Raza; Faiz Anwer; Jack Khouri; Rahul Banerjee; Raffaela Cassano Cassano; Surbhi Sidana; Masooma Shifa Rana; Lekha Mikkilineni; Hitomi Hosoya; Shebli Atrash; Christopher Ferreri; Cindy Varga; Douglas W. Sborov; Shonali Midha; Omar Nadeem; Ariel Grajales-Cruz; Rachid Baz; Brandon Blue; Ciara Freeman; Frederick L. Locke; Krina K. Patel; Yi Lin; Shaji K. Kumar; Doris K. Hansen; Larry D. Anderson Jr; Peter M. Voorhees; Omar Castaneda-Puglianini
errShare
errSave
Efficacy and Safety of BCMA-Targeted Therapies in Relapsed or Refractory AL Amyloidosis: A Descriptive Pooled Analysis
err2026-07-22
err0
errOAAI
errRaghad Alqazaqi; Sean Taasan; William Schwartzman; Adeel M Khan; Aimaz Afrough; Mohammad Faizan Zahid; Carolina Schinke; Frits van Rhee; Larry D Anderson; Vaishali Sanchorawala; Samer Al Hadidi
errShare
errSave
Idecabtagene vicleucel and endogenous T-cell phenotypes linked to progression-free survival in relapsed multiple myeloma
err2026-07-02
err0
errOAAI
errBruno Paiva; Irene Manrique; Ethan Thompson; Timothy B. Campbell; Camila Guerrero; Nathan Martin; Larry D. Anderson Jr.; Jesús G. Berdeja; Sagar Lonial; Noopur S. Raje; Yi Lin; Philippe Moreau; Jesús F. San-Miguel; Nikhil C. Munshi; Shari Kaiser
errShare
errSave
Arlocabtagene autoleucel—a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myeloma
errBlood
IF23.1
err2026-06-04
err0
errOAAI
errSusan Bal; Myo Htut; Omar Nadeem; Larry D Anderson; Tara Gregory; Mehmet Hakan Koçoğlu; Adriana C Rossi; Tom Martin; Daniel N Egan; Luciano J Costa; Hongxiang Hu; Jinjie Chen; Shaoyi Li; Lisa M Kelly; Naomey Sarkis; Safiyyah Ziyad; Kristina M Jordahl; Wei-Ming Kao; Allison J Kaeding; Michael R Burgess
errShare
errSave
How I Treat Plasma Cell Leukemia
errBlood
IF23.1
err2026-05-05
err0
PREAI
errSamer Al Hadidi; Frits van Rhee; Larry D Anderson
errShare
errSave
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study
err2026-04-14
err0
errOAAI
errDoris K. Hansen; Danai Dima; Hira Mian; Jakob Devos; Ruta Brazauskas; Temitope Oloyede; Aimaz Afrough; Nausheen Ahmed; Larry Anderson; Rahul Banerjee; Jesus G. Berdeja; Aram Bidikian; Binod Dhakal; Ajoy Dias; Yvonne Efebera; Muhammad Salman Faisal; Lohith Gowda; Hamza Hashmi; Abu-Sayeef Mirza; Meera Mohan; Ravi Narra; Ashley E. Rosko; Mark Schroeder; Taiga Nishihori; Heather Landau; Saad Usmani; Marcelo C. Pasquini; Othman S. Akhtar; Surbhi Sidana; Krina K. Patel
errShare
errSave
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium
err2026-03-27
err0
errOAAI
errAndrew J. Portuguese; James A. Davis; Shahzad Raza; Omar Castaneda Puglianini; Ciara Freeman; Melissa Alsina; Corbin Wright; Brandon J. Blue; Rachid C. Baz; Kenneth H. Shain; Utkarsh Goel; Jack Khouri; Faiz Anwer; Hossam M. Ali; Oren Pasvolsky; Mahmoud Gaballa; Krina Patel; Hector Garcia-Pleitez; Damian Mikulski; Lindsay Fogel; Eli Zolotov; Aishwarya Sannareddy; Aimaz Afrough; Larry D. Anderson; Kelley Julian; Danai Dima; Rahul Banerjee; Emily C. Liang; Raffaella Cassano Cassano; Megan M. Herr; Hamza Hassan; Leyla Shune; Jeries Kort; Shonali Midha; Omar Nadeem; Surbhi Sidana; Yi Lin; Frederick L. Locke; Doris K. Hansen; Douglas Sborov; Noa Biran; Ariel Grajales-Cruz
errShare
errSave
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience
err2025-11-28
err0
errOAAI
errAimaz Afrough; Danai Dima; Beatrice Razzo; Utkarsh Goel; Aishwarya Sannareddy; Oren Pasvolsky; Mariola A. Vazquez-Martinez; Christopher J. Ferreri; Rahul Banerjee; Jack Khouri; James A. Davis; Mahmoud R. Gaballa; Alex Lieberman-Cribbin; Masooma S. Rana; Kelley Julian; Faiz Anwer; Leyla Shune; Shaun DeJarnette; Ariel F. Grajales-Cruz; Evguenia Ouchveridze; Gabriel De Avila; Sandra P. Susanibar-Adaniya; Andrew J. Portuguese; Daniel Schrum; Erin Eberwein; Hitomi Hosoya; Lekha Mikkilineni; Gurbakhash Kaur; Joseph P. McGuirk; Adriana Rossi; Megan M. Herr; Omar Castaneda; Frederick L. Locke; Shahzad Raza; Yi Lin; Shebli Atrash; Douglas W. Sborov; Peter M. Voorhees; Shambavi Richard; Alfred L. Garfall; Surbhi Sidana; Krina K. Patel; Doris K. Hansen; Andrew J. Cowan; Larry D. Anderson; Hans C. Lee
errShare
errSave
The Real-World Safety and Efficacy of Bispecific T-Cell Engager Therapy in Systemic AL Amyloidosis
err2025-11-01
err0
PREAI
errRees, Matthew J.; Khouri, Jack; Grajales-cruz, Ariel F.; Zanwar, Saurabh S.; Goel, Utkarsh; Midha, Shonali; Kelley, Julian; Puglianini, Omar Castaneda; Corraes, Andre De Menezes Silva; Raza, Shahzad; Davis, James A.; Green, Kimberly; Hansen, Doris K.; Banerjee, Rahul; Sidana, Surbhi; Patel, Krina K.; Bianchi, Giada; Sborov, Douglas W.; Lee, Sarah; Kumar, Shaji K.; Baz, Rachid; Anwer, Faiz; Mikkilineni, Lekha; Nadeem, Omar; Lin, Yi; Anderson Jr, Larry D.
errShare
errSave
Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses
err2025-10-06
err0
errOAAI
errLaahn Foster; Larry D. Anderson; Alfred Chung; Chakra P. Chaulagain; Erin Pettijohn; Andrew J. Cowan; Caitlin Costello; Sarah Larson; Douglas W. Sborov; Kenneth H. Shain; Rebecca Silbermann; Peter Voorhees; Maria Krevvata; Huiling Pei; Sharmila Patel; Vipin Khare; Annelore Cortoos; Robin Carson; Thomas S. Lin; Ashraf Badros
errShare
errSave
Safety and Efficacy of BCMA directed Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Plasma Cell Leukemia
err2025-09-01
err0
errOAAI
errGliceida M. Galarza Fortuna; Lauren Peres; Elena Nazarenko; Andre De Menezes Silva Corraes; Vanna N. Hovanky; Leyla Shune; Joseph McGuirk; Gabe De Avilla; Jack Khouri; Danai Dima; Mahmoud Gaballa; Binod Dhakal; Peter Forsberg; Amandeep Godara; Aimaz Afrough; Larry Anderson; Megan M. Herr; James A. Davis; Hashim Mann; Sneha Purvey; William Clark; Myo Htut; Amer Beitinjaneh; Denise L. Pereira; Mehmet H. Kocoglu; Cristopher Ferreri; Shebli Atrash; Peter M. Voorhees; Adriana Rossi; Richard Shambavi; Hamza Hashmi; Krina Patel; Surbhi Sidana; Yi Lin; Doris K. Hansen; Douglas W. Sborov
errShare
errSave
Early peripheral blood and bone marrow MRD as prognostic markers in quadruplet-treated multiple myeloma without transplant
err2025-08-19
err0
errOAAI
errBenjamin A. Derman; Jennifer Cooperrider; Anna Pula; Heidi Simmons; Tadeusz Kubicki; Jeffrey Zonder; Aimaz Afrough; David Grinblatt; Jacalyn Rosenblatt; Larry D. Anderson Jr.; Andrew Kin; David Avigan; Sunil Narula; Shayan Rayani; Ken Jiang; Ajay Major; Theodore Karrison; Allison Jacob; Andrzej J. Jakubowiak
errShare
errSave
Optimizing Selection of Bridging Therapies Prior to CAR-T Therapy Administration for Multiple Myeloma: Clinical Pearls From an Expert Roundtable
err2025-08-07
err0
PREAI
errSikander Ailawadhi; Larry D. Anderson; Binod Dhakal; Leyla Shune; Douglas W. Sborov; Doris K. Hansen
errShare
errSave
Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy
errBlood
IF23.1
err2025-08-05
err0
PREAI
errBinod Dhakal; Othman S. Akhtar; David Fandrei; Alexandria Jensen; Rahul Banerjee; Darren Pan; Shambavi Richard; Reed Friend; Matthew Rees; Patrick Costello; Mariola Vazquez Martinez; Oren Pasvolsky; Charlotte Wagner; James A. Davis; Omar Castaneda Puglianini; Ran Reshef; Aimaz Afrough; Danai Dima; Manisha Bhutani; Omar Nadeem; Ricardo Parrondo; Ciara Freeman; Lekha Mikkilineni; Shahzad Raza; Larry D. Anderson Jr; Prashant Kapoor; Hitomi Hosoya; Saurabh Chhabra; Ariel Grajales-Cruz; Mahmoud Gaballa; Shonali Midha; Melissa Alsina; Douglas Sborov; Krina Patel; Yi Lin; Christopher Ferreri; Nico Gagelmann; Anupama Kumar; Doris Hansen; Andrew Cowan; Luciano J. Costa; Maximilian Merz; Surbhi Sidana
errShare
errSave
Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium
err2025-06-25
err0
errOAAI
errDanai Dima; Mariola A. Vazquez-Martinez; James A. Davis; Utkarsh Goel; Aimaz Afrough; Aishwarya Sannareddy; Oren Pasvolsky; Beatrice Razzo; Rahul Banerjee; Jack Khouri; Ariel Grajales-Cruz; Alex Lieberman-Cribbin; Masooma Shifa Rana; Kelley Julian; Shaun DeJarnette; Andrew J. Portuguese; Mahmoud R. Gaballa; Gabriel De Avila; Sandra Susaniba Adaniya; Shahzad Raza; Megan M. Herr; Evguenia Ouchveridze; Tiffany Richards; Hitomi Hosoya; Lekha Mikkilineni; Gurbakhash Kaur; Omar Castaneda Puglianini; Adriana Rossi; Yi Lin; Shebli Atrash; Douglas Sborov; Kenneth H. Shain; Peter M. Voorhees; Shambavi Richard; Alfred L. Garfall; Doris K. Hansen; Surbhi Sidana; Krina K. Patel; Andrew J. Cowan; Larry D. Anderson; Hans C. Lee; Faiz Anwer; Christopher J. Ferreri; Leyla Shune
errShare
errSave
Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the US Multiple Myeloma Immunotherapy Consortium
err2025-05-09
err0
errOAAI
errPasvolsky, Oren; Dima, Danai; Feng, Lei; Dong, Wenli; Richards, Tiffany; Davis, James A.; Afrough, Aimaz; Vazquez-Martinez, Mariola; Sannareddy, Aishwarya; Goel, Utkarsh; Banerjee, Rahul; Khouri, Jack; Cervoni, Frances; Gaballa, Mahmoud R.; Lieberman-Cribbin, Alex; Rana, Masooma Shifa; Julian, Kelley; Ferreri, Christopher J.; Shune, Leyla; Dejarnette, Shaun; Bhurtel, Evguenia; Susanibar Adaniya, Sandra; Portuguese, Andrew; Hosoya, Hitomi; Mikkilineni, Lekha; Kaur, Gurbakhash; Rossi, Adriana; Herr, Megan M.; Schrum, Daniel; Lin, Chenyu; Raza, Shahzad; Lin, Yi; Midha, Shonali; Omar, Nadeem; Atarsh, Shebli; McGuirk, Joseph; Sborov, Douglas; Voorhees, Peter; Anwer, Faiz; Alsina, Melissa; Freeman, Ciara; Garfall, Alfred L.; Razzo, Beatrice M.; Sidana, Surbhi; Cowan, Andrew J.; Anderson Jr, Larry D.; Hansen, Doris K.; Richard, Shambavi; Patel, Krina K.; Lee, Hans C.; Grajales-Cruz, Ariel
errShare
errSave
A Phase 2 Trial Investigating Epcoritamab in Patients with Previously Treated Waldenstrom Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (WM-NET3)
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errvon Keudell, Gottfried; Logan, Emma K.; Redd, Robert A.; Sarosiek, Shayna R.; Branagan, Andrew R.; Anderson Jr, Larry D.; Dittus, Christopher; Treon, Steven P.; Castillo, Jorge J.
errShare
errSave
Efficacy of Stem Cell Boost (SCB) for Chimeric Antigen Receptor T Cell (CAR-T)-Related Hematologic Toxicity in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)- a Multi-Center Real World Experience
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errVarga, Cindy; Robinson, Myra; Davis, James; Hashmi, Hamza; Martin, Thomas; Kumar, Anupama Deepa; Sborov, Douglas W.; Wagner, Charlotte B.; Hansen, Doris K.; Castaneda, Omar; Shune, Leyla O.; Dejarnette, Shaun; Afrough, Aimaz; Anderson, Larry D., Jr.; Dhakal, Binod; Smith, Kinaya; Herr, Megan M.; Richard, Shambavi; Lieberman-Cribbin, Alex; Sherbenou, Daniel W.; Forsberg, Peter A.; Voorhees, Peter M.
errShare
errSave
A plain language summary of the final analysis of the GRIFFIN study of daratumumab plus lenalidomide, bortezomib, and dexamethasone for people with newly diagnosed multiple myeloma
err2024-10-25
err0
errOAAI
errVoorhees, Peter M.; Sborov, Douglas W.; Laubach, Jacob; Kaufman, Jonathan L.; Reeves, Brandi; Rodriguez, Cesar; Silbermann, Rebecca; Costa, Luciano J.; Anderson, Larry D.; Nathwani, Nitya; Shah, Nina; Bumma, Naresh; Efebera, Yvonne A.; Holstein, Sarah A.; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M.; Orlowski, Robert Z.; Shain, Kenneth H.; Cowan, Andrew J.; Dinner, Shira; Gries, Katharine S.; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Lin, Thomas S.; Usmani, Saad Z.; Richardson, Paul G.
errShare
errSave